Fifty-three percent of seniors have not enrolled in a Medicare Part D and do not plan to join the drug benefit, according to a DSS Research survey of 600 elderly adults. The non-buyers used the least amount of medical services, took fewer prescriptions, spent less on drugs, and were more affluent and better educated than seniors who have enrolled or said they intend to enroll in Part D.
FDA Expands Tenofovir Alafenamide Indication to Treat HBV in Patients as Young as 6
March 28th 2024Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.